Analysts expect Connect Biopharma Holdings Ltd to report revenue of 7.01 M for 2026, against a range of 6.34 M to 7.69 M. The most recent reported year, 2025, came in at 62,900.00, a 21.4% miss against the 80,044.89 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 25.86 M | 62,900.00 | - | - | ||
| High Estimate | 0.00 | 0.00 | 21.95 M | 26.44 M | 83,583.11 | 7.69 M | 17.01 M | ||
| Low Estimate | 0.00 | 0.00 | 19.39 M | 23.31 M | 76,506.67 | 6.34 M | 14.20 M | ||
| Consensus Estimate | 0.00 | 0.00 | 20.67 M | 24.87 M | 80,044.89 | 7.01 M | 15.60 M |
Analysts expect Connect Biopharma Holdings Ltd to report earnings per share of -0.94 for 2026, against a range of -0.99 to -0.89. The most recent reported year, 2025, came in at -0.98, a 6.7% beat against the -1.05 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -3.99 | -2.10 | -1.10 | -0.28 | -0.98 | - | - | ||
| High Estimate | -3.30 | -2.10 | -0.73 | -0.22 | -0.97 | -0.89 | -0.73 | ||
| Low Estimate | -3.94 | -2.30 | -0.85 | -0.26 | -1.13 | -0.99 | -0.87 | ||
| Consensus Estimate | -3.62 | -2.20 | -0.79 | -0.24 | -1.05 | -0.94 | -0.80 |
Pull Wall Street consensus for Connect Biopharma Holdings Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CNTB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CNTB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CNTB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();